Capital Investment Counsel Inc’s Gilead Sciences GILD Stock Holding History

Capital Investment Counsel Inc’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$259K	Hold	2,050	–	–	0.03%	181
2026 Q1	$286K	Hold	2,050	–	–	0.04%	161
2025 Q4	$252K	Hold	2,050	–	–	0.03%	174
2025 Q3	$228K	Hold	2,050	–	–	0.03%	185
2025 Q2	$227K	Hold	2,050	–	–	0.03%	180
2025 Q1	$230K	Buy	+2,050	New	+$212K	0.03%	173
2021 Q2	–	Sell	-3,411	Closed	-$220K	–	200
2021 Q1	$220K	Buy	+3,411	New	+$220K	0.06%	149
2020 Q4	–	Sell	-3,561	Closed	-$225K	–	181
2020 Q3	$225K	Buy	3,561 +250	+8%	+$17.3K	0.07%	133
2020 Q2	$255K	Buy	+3,311	New	+$254K	0.1%	113

Other funds holding GILD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return

SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Mitsubishi UFJ Asset Management Tokyo, Japan $180B AUM 37.51% 1-Year Est. Return

Capital Investment Counsel Inc's GILD Position: Q2 2026 in Review

Capital Investment Counsel Inc held its Gilead Sciences (GILD) position steady in Q2 2026 at 2,050 shares worth $259K. The position accounts for 0.03% of the portfolio, ranked #181.

Capital Investment Counsel Inc first reported a position in GILD in Q2 2020 and has held it in 9 quarters since. The position peaked at $286K in Q1 2026. 1,412 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

Capital Investment Counsel Inc held 2,050 shares of Gilead Sciences worth $259K as of Q2 2026.
Capital Investment Counsel Inc left its Gilead Sciences share count unchanged in Q2 2026.
Gilead Sciences made up 0.03% of Capital Investment Counsel Inc's portfolio in Q2 2026, its #181 holding.
Capital Investment Counsel Inc first reported a position in Gilead Sciences in Q2 2020 and has held it in 9 quarters since.
Capital Investment Counsel Inc's Gilead Sciences position peaked at $286K in Q1 2026.
1,412 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Capital Investment Counsel Inc's 13F filing for Q2 2026, filed 27 Jul 2026.